Current role and future direction of osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer
J Thorac Dis
.
2019 Jan;11(1):39-41.
doi: 10.21037/jtd.2018.12.37.
Authors
Byeong-Ho Jeong
1
,
Sang-Won Um
1
Affiliation
1
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
PMID:
30863565
PMCID:
PMC6384381
DOI:
10.21037/jtd.2018.12.37
No abstract available
Publication types
Editorial
Comment